Merino RJA, Taracena PS, Díaz GEJ, Rodríguez WFL

Language: Spanish
References: 38
Page: 92-100
PDF size: 184.87 Kb.

ABSTRACT

In the last 10 years, a lot of articles have been published related to the human microbiota, especially in the gut. This ecosystem of microorganisms, as a whole, has a genome broader than human, that gives microbiota the ability to regulate processes that converge in the physiology of immunological pathways and in the pathophysiology of intestinal and extra-intestinal diseases. Applying these new concepts in the clinical, para-clinical and therapeutic evaluation of a patient, today represents a challenge, because factors involved in the formation of the microbiota, in the changes it presents throughout life and the factors that influence in modify and maintain its composition, diversity and metabolism, are highly variable. Some are beyond our control, such as the type of birth, but others not, such as diet, fiber consumption and probiotics, they interfere significantly with modifications to microbiota and subsequently to the general health of the guest. The following review consists in a synthesis of the most relevant functional aspects of the intestinal microbiota, this with the aim to spread the topic and to motivate in new research focused on clinical-therapeutic applications.

REFERENCES

1. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012; 148 (6): 1258-1270.

2. Heintz-Buschart A, Wilmes P. Human gut microbiome: function matters. Trends Microbiol. 2018; 26 (7): 563-574.

3. Aagaard K, Ma J, Antony KM, Ganu R, Petrosino J, Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med. 2014; 6 (237): 237ra65.

4. Lynch SV, Pedersen O. The human intestinal microbiome in health and disease. N Engl J Med. 2016; 375 (24): 2369-2379.

5. Gómez-Duque M, Acero F. Composición y funciones de la flora bacteriana intestinal. Repert Med Cir. 2011; 20 (2): 74-82.

6. Ottman N, Smidt H, de Vos WM, Belzer C. The function of our microbiota: who is out there and what do they do? Front Cell Infect Microbiol. 2012; 2: 104.

7. Rescigno M. The microbiota revolution: excitement and caution. Eur J Immunol. 2017; 47 (9): 1406-1413.

8. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology. 2006; 131 (1): 117-129.

9. Jandhyala SM, Talukdar R, Subramanyam C, Vuyyuru H, Sasikala M, Nageshwar Reddy D. Role of the normal gut microbiota. World J Gastroenterol. 2015; 21 (29): 8787-8803.

10. Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016; 7 (3): 189-200.

11. Makki K, Deehan EC, Walter J, Bäckhed F. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host Microbe. 2018; 23 (6): 705-715.

12. Gubert C, Kong G, Renoir T, Hannan AJ. Exercise, diet and stress as modulators of gut microbiota: Implications for neurodegenerative diseases. Neurobiol Dis. 2020; 134: 104621.

13. Valdes AM, Walter J, Segal E, Spector TD. Role of the gut microbiota in nutrition and health. BMJ. 2018; 361: k2179.

14. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol. 2013; 108 (4): 500-508.

15. Lindskog Jonsson A, Caesar R, Akrami R, Reinhardt C, Fak Hallenius F, Borén J et al. Impact of gut microbiota and diet on the development of atherosclerosis in Apoe-/- Mice. Arterioscler Thromb Vasc Biol. 2018; 38 (10): 2318-2326.

16. Vallianou NG, Tzortzatou-Stathopoulou F. Microbiota and cancer: an update. J Chemother. 2019; 31 (2): 59-63.

17. Garrett WS. Cancer and the microbiota. Science. 2015; 348 (6230): 80-86.

18. Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 2015; 350 (6264): 1084-1089.

19. Vétizou M, Pitt JM, Daillére R, Lepage P, Waldschmitt N, Flament C et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015; 350 (6264): 1079-1084.

20. Konishi H, Fujiya M, Tanaka H, Ueno N, Moriichi K, Sasajima J et al. Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis. Nat Commun. 2016; 7: 12365.

21. Cox AJ, West NP, Cripps AW. Obesity, inflammation, and the gut microbiota. Lancet Diabetes Endocrinol. 2015; 3 (3): 207-215.

22. Breton J, Tennoune N, Lucas N, Francois M, Legrand R, Jacquemot J et al. Gut commensal E. coli proteins activate host satiety pathways following nutrient-induced bacterial growth. Cell Metab. 2016; 23 (2): 324-334.

23. Marshall JK, Thabane M, Garg AX, Clark WF, Moayyedi P, Collins SM; Walkerton Health Study Investigators. Eight year prognosis of postinfectious irritable bowel syndrome following waterborne bacterial dysentery. Gut. 2010; 59 (5): 605-611.

24. Wang HX, Wang YP. Gut microbiota-brain axis. Chin Med J (Engl). 2016; 129 (19): 2373-2380.

25. Quigley EMM. Microbiota-brain-gut axis and neurodegenerative diseases. Curr Neurol Neurosci Rep. 2017; 17 (12): 94.

26. Kang DW, Adams JB, Coleman DM, Pollard EL, Maldonado J, McDonough-Means S et al. Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Sci Rep. 2019; 9 (1): 5821.

27. Zhang YG, Wu S, Yi J, Xia Y, Jin D, Zhou J et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017; 39 (2): 322-336.

28. Yang D, Zhao D, Shah SZA, Wu W, Lai M, Zhang X et al. Implications of gut microbiota dysbiosis and metabolic changes in prion disease. Neurobiol Dis. 2020; 135: 104704.

29. Belkaid Y, Harrison OJ. Homeostatic Immunity and the Microbiota. Immunity. 2017; 46 (4): 562-576.

30. Trama AM, Moody MA, Alam SM, Jaeger FH, Lockwood B, Parks R et al. HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria. Cell Host Microbe. 2014; 16 (2): 215-226.

31. Costa M, Weese JS. Methods and basic concepts for microbiota assessment. Vet J. 2019; 249: 10-15.

32. Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: diagnostic tools and therapeutic strategies. Science. 2018; 359 (6382): 1366-1370.

33. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A. 2010; 107 (33): 14691-14696.

34. Holscher HD. Dietary fiber and prebiotics and the gastrointestinal microbiota. Gut Microbes. 2017; 8 (2): 172-184.

35. Kim SK, Guevarra RB, Kim YT, Kwon J, Kim H, Cho JH et al. Role of probiotics in human gut microbiome-associated diseases. J Microbiol Biotechnol. 2019; 29 (9): 1335-1340.

36. Mantegazza C, Molinari P, D'Auria E, Sonnino M, Morelli L, Zuccotti GV. Probiotics and antibiotic-associated diarrhea in children: A review and new evidence on Lactobacillus rhamnosus GG during and after antibiotic treatment. Pharmacol Res. 2018; 128: 63-72.

37. Islam SU. Clinical uses of probiotics. Medicine (Baltimore). 2016; 95 (5): e2658.

38. Kim N, Yun M, Oh YJ, Choi HJ. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics. J Microbiol. 2018; 56 (3): 172-182.